CBS 2019
CBSMD教育中心
中 文

双重抗血小板治疗持续时间

Abstract

Recommended Article

Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease A Platelet Function Modulator of Thrombin Activation Is Causally Linked to Cardiovascular Disease and Affects PAR4 Receptor Signaling Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy: A Secondary Analysis of the LEADERS FREE Randomized Clinical Trial Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGY Inhibition of Platelet Aggregation After Coronary Stenting in Patients Receiving Oral Anticoagulation A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial

Original Research07 December 2020

JOURNAL:Sci Rep. Article Link

Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease

Y-C Tung, C-T Kuo, C-J Chang et al. Keywords: bleeding risk; DAPT; CAD

Full Text PDF

网站资料更新中...